Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Si Liu

Showing results (611-620 of 615) with videos related to

Pageof 62
Sort By:
You have reached the last page of results.This site can display upto 615 results.
Frontiers in Immunology|January 31, 2022
The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian CancerChen Liu, Yuhan Huang, Yaoyuan Cui, et al.
Acta Pharmacologica Sinica|January 24, 2024
Pharmacologically significant constituents collectively responsible for anti-sepsis action of XueBiJing, a Chinese herb-based intravenous formulationChen Cheng, Chao Ren, Mu-Zi Li, et al.
Cancer Letters|November 24, 2025
A two-stage genome-wide association study to identify novel genetic loci associated with irAEs in lung cancer patients receiving PD-1/PD-L1 inhibitorsLei She, Juan Chen, Jun-Yan Liu, et al.
Cell Genomics|February 13, 2023
Multi-omics characterization of silent and productive HPV integration in cervical cancerJunpeng Fan, Yu Fu, Wenju Peng, et al.
Nature Medicine|July 8, 2025
Recombinant monoclonal antibody siltartoxatug versus plasma-derived human tetanus immunoglobulin for tetanus: a randomized, double-blind, active-controlled, phase 3 trialZijing Liang, Si Liu, Wei Guo, et al.
Pageof 62

Showing results (611-620 of 615) with videos related to

Sort By:
Pageof 62
You have reached the last page of results.This site can display upto 615 results.
Frontiers in Immunology|January 31, 2022
The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian CancerChen Liu, Yuhan Huang, Yaoyuan Cui, et al.
Acta Pharmacologica Sinica|January 24, 2024
Pharmacologically significant constituents collectively responsible for anti-sepsis action of XueBiJing, a Chinese herb-based intravenous formulationChen Cheng, Chao Ren, Mu-Zi Li, et al.
Cancer Letters|November 24, 2025
A two-stage genome-wide association study to identify novel genetic loci associated with irAEs in lung cancer patients receiving PD-1/PD-L1 inhibitorsLei She, Juan Chen, Jun-Yan Liu, et al.
Cell Genomics|February 13, 2023
Multi-omics characterization of silent and productive HPV integration in cervical cancerJunpeng Fan, Yu Fu, Wenju Peng, et al.
Nature Medicine|July 8, 2025
Recombinant monoclonal antibody siltartoxatug versus plasma-derived human tetanus immunoglobulin for tetanus: a randomized, double-blind, active-controlled, phase 3 trialZijing Liang, Si Liu, Wei Guo, et al.
Pageof 62